Naslov
46. Impact of Reforms to Enhence the Quality and Efficiency of Statin Prescribing Across 20 European Countries.

Autori
Godman B, Wettermark B, Vlahović-Palčevski V, Schwabe U, Gulbinovič J, Laius O, Diogene E, Paterson K, Martikainen J, Bennett K, Gustafsson LL.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Basic & Clinical Pharmacology and Toxicology / Brosen, Kim - Oxford : Wiley-Blackwell, 2009, 35-35

Skup
9tn Congress of the EACPT

Mjesto i datum
Edinburgh, Ujedinjeno Kraljevstvo, 12.07.2009. - 15.07.2009

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
drug prescribing; reforms; quality

Sažetak
Statin utilisation increased across all 18 countries in line with expectations. Simvastatin generally dominated utilisation especially following generics, with variable utilisation of atorvastatin. Reimbursement restrictions were most successful in moderating atorvastatin prescribing. Statin costs (€)/ DDD decreased with increasing use of generic simvastatin helping to moderate and in some cases reducing statin expenditure. Cost/ DDD for generic simvastatin varied widely depending on for instance compulsory generic substitution, whether branded generic prescribing, and the extent of demand side initiatives. Opportunity for clinical pharmacologists and others to further improve the quality and efficiency of prescribing.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA